NCT05074706View on ClinicalTrials.gov

Evaluation of the Immune Response to Sars-Covid-19 Vaccines in Haematological Patients: Prospective Single Center Study

CompletedOBSERVATIONAL
Enrollment

700

Participants

Timeline

Start Date

June 9, 2021

Primary Completion Date

June 15, 2022

Study Completion Date

June 15, 2022

Conditions
Hematologic Diseases
Interventions
BIOLOGICAL

IgG antibodies to Sars-Cov-2

Samples will be collected between 30 and 60 days after second vaccine dose.

BIOLOGICAL

QuantiFERON SARS-CoV-2 test

Samples will be collected within 9 months after completion of the vaccination series

Trial Locations (1)

20900

San Gerardo Hospital, Monza

All Listed Sponsors
collaborator

San Gerardo Hospital

OTHER

lead

University of Milano Bicocca

OTHER